Accuray (ARAY) Net Income towards Common Stockholders (2010 - 2026)
Accuray (ARAY) posted quarterly Net Income towards Common Stockholders of -$12.2 million for Q1 2026, down 348.01% year-over-year from $4.9 million in Q1 2025, and up 14.2% quarter-over-quarter from -$14.2 million in Q4 2025.
Accuray (ARAY) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Accuray's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$12.2 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 348.01% year-over-year to -$12.2 million; the TTM figure through Mar 2026 stood at -$54.9 million (down 3168.57% YoY), while the FY2025 annual figure was -$1.6 million, up 89.77% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$12.2 million, up from -$14.2 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $2.5 million in Q4 2024, with the low at -$120.5 million in Q2 2023.
- The 5-year median for Net Income towards Common Stockholders is -$6.7 million (2023), against an average of -$13.9 million.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders tumbled 1191.44% in 2022, then soared 126.37% in 2024.
- Accuray's Net Income towards Common Stockholders stood at -$1.9 million in 2022, then slumped by 413.39% to -$9.6 million in 2023, then jumped by 126.37% to $2.5 million in 2024, then plunged by 658.57% to -$14.2 million in 2025, then grew by 14.2% to -$12.2 million in 2026.
- Business Quant data shows ARAY's Net Income towards Common Stockholders at -$12.2 million in Q1 2026, -$14.2 million in Q4 2025, and -$21.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Accuray | 37.50 Mn | -2.20 Mn | 25.29 Mn | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.16 Mn |
| Dec 31, 2025 | -14.17 Mn |
| Sep 30, 2025 | -21.68 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | -3.95 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | -18.93 Mn |
| Dec 31, 2023 | -9.62 Mn |
| Sep 30, 2023 | -2.97 Mn |
| Jun 30, 2023 | -120.47 Mn |
| Mar 31, 2023 | -6.72 Mn |
| Dec 31, 2022 | -1.87 Mn |
| Sep 30, 2022 | -5.45 Mn |
| Jun 30, 2022 | -11.35 Mn |
| Mar 31, 2022 | -1.96 Mn |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2021 | -1.03 Mn |
| Jun 30, 2021 | 1.04 Mn |